$ENRT
Enertopia Corp.

2024 Q4 Form 10-K Financial Statement

#000106299324019582 Filed on November 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $156.7K
YoY Change 0.08%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $665.6K
YoY Change -45.64%
Operating Profit -$665.6K
YoY Change -45.64%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $64.50K
YoY Change -28.12%
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$999.0K
YoY Change -45.47%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 155.2M shares 155.2M shares 155.2M shares
Diluted Shares Outstanding 155.2M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $247.4K
YoY Change -80.19%
Cash & Equivalents $179.9K
Short-Term Investments $67.52K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $78.79K
Receivables $5.927K
Other Receivables
Total Short-Term Assets $332.1K
YoY Change -75.36%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.50K
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $332.1K
Total Long-Term Assets $10.50K
Total Assets $342.6K
YoY Change -74.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $316.0K
YoY Change 0.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $316.0K
YoY Change -4.98%
SHAREHOLDERS EQUITY
Retained Earnings -$15.52M
YoY Change 6.87%
Common Stock $155.2K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.81K
YoY Change
Total Liabilities & Shareholders Equity $342.6K
YoY Change -74.77%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024
OPERATING ACTIVITIES
Net Income -$999.0K
YoY Change -45.47%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$665.8K
YoY Change -45.08%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $586.1K
YoY Change -31.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$665.8K
Cash From Investing Activities $586.1K
Cash From Financing Activities $0.00
Net Change In Cash -$79.69K
YoY Change -77.59%
FREE CASH FLOW
Cash From Operating Activities -$665.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8150000 shares
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
179893 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
155167 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2024 enrt Rental Commitment
RentalCommitment
853 cad
CY2024 dei Entity File Number
EntityFileNumber
000-51866
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5927 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1347708 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
78794 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
89338 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
332130 usd
CY2023Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
10500 usd
CY2023Q3 us-gaap Assets
Assets
1358208 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
60057 usd
CY2023 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
181258 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-665633 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1224585 usd
CY2024 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1003760 usd
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
136681 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
155166088 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
155142937 shares
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4605 usd
CY2024 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
586122 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
854599 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
586122 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1750000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.08
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.09
CY2023Q3 enrt Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155166088 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155166088 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8150000 shares
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2024 dei Entity Address Country
EntityAddressCountry
CA
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-08-31
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
KELOWNA
CY2023Q3 us-gaap Marketable Securities
MarketableSecurities
989307 usd
CY2024Q3 us-gaap Liabilities
Liabilities
316032 usd
CY2023Q3 us-gaap Liabilities
Liabilities
332600 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155166088 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155166088 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
155167 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
342630 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1358208 usd
CY2024 us-gaap Professional Fees
ProfessionalFees
48637 usd
CY2024 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
172448 usd
CY2024 us-gaap Other Expenses
OtherExpenses
64497 usd
CY2023 us-gaap Legal Fees
LegalFees
98229 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64304 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
110789 usd
CY2024 enrt Mineral Exploration Costs
MineralExplorationCosts
55480 usd
CY2023 enrt Mineral Exploration Costs
MineralExplorationCosts
464665 usd
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
156680 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
156561 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
665633 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1224585 usd
CY2024 enrt Marketable Securities Unrealized Foreign Exchange Loss
MarketableSecuritiesUnrealizedForeignExchangeLoss
-6596 usd
CY2023 enrt Marketable Securities Unrealized Foreign Exchange Loss
MarketableSecuritiesUnrealizedForeignExchangeLoss
-130444 usd
CY2024 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-17196 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-47213 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259581 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
615207 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1428 usd
CY2024 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-23804 usd
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-183490 usd
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
233194 usd
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-209462 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-384757 usd
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
72 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4973369 shares
CY2022Q3 enrt Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.04
CY2024 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-999010 usd
CY2023 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1832178 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2970455 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2734816 usd
CY2024Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
128882 usd
CY2023Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
1605 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-3231303 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-2977779 usd
CY2024Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
14145026 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12651469 usd
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-355626 usd
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
#7 1873 SPALL RD
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15397607 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-998484 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
854599 usd
CY2024 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1750000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.06
CY2023 enrt Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod
0 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001346022
CY2024 dei Document Type
DocumentType
10-K
CY2024Q3 us-gaap Assets
Assets
342630 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
315404 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1212225 usd
CY2024 dei Entity Registrant Name
EntityRegistrantName
ENERTOPIA CORP.
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V1Y 4R2
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17196 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155166088 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155166088 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15397607 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
27805 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1026289 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
-1207 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
-681 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1025608 usd
CY2024 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-526 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26598 usd
CY2024 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2293 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-7749 usd
CY2024 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-1265781 usd
CY2023 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-564346 usd
CY2024 enrt Marketable Securities Realized Foreign Exchange Loss
MarketableSecuritiesRealizedForeignExchangeLoss
-67053 usd
CY2023 enrt Marketable Securities Realized Foreign Exchange Loss
MarketableSecuritiesRealizedForeignExchangeLoss
-41735 usd
CY2024 us-gaap Profit Loss
ProfitLoss
-999010 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-1832178 usd
CY2024 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-998484 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1831497 usd
CY2024 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-526 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-681 usd
CY2024 us-gaap Profit Loss
ProfitLoss
-999010 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-1832178 usd
CY2024 enrt Marketable Securities Unrealized Gain Loss Total
MarketableSecuritiesUnrealizedGainLossTotal
1003761 usd
CY2023 enrt Marketable Securities Unrealized Gain Loss Total
MarketableSecuritiesUnrealizedGainLossTotal
136681 usd
CY2024 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-6596 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-130444 usd
CY2024 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-1265781 usd
CY2023 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-564346 usd
CY2024 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-67053 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-41735 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2000 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
16098 usd
CY2023 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
1015108 usd
CY2024Q3 us-gaap Cash
Cash
61048 usd
CY2023Q3 us-gaap Cash
Cash
218081 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
179893 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
259581 usd
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
156680 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
156561 usd
CY2023 enrt Drilling Expenses
DrillingExpenses
325170 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.04
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155166088 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155166088 shares
CY2024Q3 enrt Number Of Shares Held In Escrow
NumberOfSharesHeldInEscrow
7000000 shares
CY2024Q3 enrt Number Of Shares Held In Escrow
NumberOfSharesHeldInEscrow
7000000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9900000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8150000 shares
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y10M28D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023 enrt Class Of Warrant Or Right Forfeited In Period
ClassOfWarrantOrRightForfeitedInPeriod
4923369 shares
CY2023Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
13593 usd
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
33915 usd
CY2024Q3 enrt Prepaid Expenses Current Office Expenses
PrepaidExpensesCurrentOfficeExpenses
1145 usd
CY2024Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
52627 usd
CY2023Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
29590 usd
CY2024Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3231303 usd
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2997779 usd
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1970188
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9482 usd
CY2024Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
10500 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
316032 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15524969 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14526485 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2855786 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3555 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10544 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-49969 usd
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
628 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21958 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-665810 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-79688 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei City Area Code
CityAreaCode
250
CY2024 dei Local Phone Number
LocalPhoneNumber
870-2219
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Public Float
EntityPublicFloat
2657000 usd
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
155166088 shares
CY2024 dei Auditor Name
AuditorName
DAVIDSON & COMPANY LLP
CY2024 dei Auditor Location
AuditorLocation
Vancouver, Canada
CY2024 dei Auditor Firm
AuditorFirmId
731
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
259581 usd
CY2024Q3 us-gaap Marketable Securities
MarketableSecurities
67516 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26598 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1025608 usd
CY2023 enrt Stock Issued During Period Value Warrants Issued For Cash
StockIssuedDuringPeriodValueWarrantsIssuedForCash
2000 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-681 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1831497 usd
CY2023 us-gaap Other Expenses
OtherExpenses
89733 usd
CY2024 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
25493 usd
CY2023 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
63293 usd
CY2024 us-gaap Legal Fees
LegalFees
78094 usd
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155166088 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155142937 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179893 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259581 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15524969 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
118845 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
41500 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>f.</strong> <strong>Accounting Estimates</strong></span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of consolidated financial statements in conformity with U.S GAAP requires us to make certain estimates, judgements and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company's accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations.</span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates.</span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant accounting estimates and assumptions are used for, but not limited to:</span></span></p> <p style="margin-left:54pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a) The Valuation of Deferred Tax Assets</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Judgement is required in determining whether deferred tax assets are recognized on the balance sheet. The recognition of deferred tax assets requires management to assess the likelihood that the Company will generate taxable income in future periods to utilize the deferred tax assets. Due to the Company's history of losses, deferred tax assets have not been recognized by the Company.</span></span></p> <div></div> <p style="margin-left:36pt;text-align:justify;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b) Value of Stock Options</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company provides compensation benefits to its employees, directors, officers, and consultants, through a stock option plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model. Expected volatility assumption used in the model is based on the historical volatility of the Company's share price. The Company uses historical data to estimate the period of option exercises for use in the valuation model. The risk-free interest rate for the expected term of the option is based on the yields of government bonds. Changes in these assumptions, especially the share price volatility and the expected life determination could have a material impact on the Company's profit and loss for the periods presented. All estimates used in the model are based on historical data which may not be representative of future results.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c) Fair value of shares issued in non cash transactions</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company at times grants common shares in lieu of cash to certain vendors for their services to the Company. The Company recognizes the associated cost in the same period and manner as if the Company paid cash for the services provided by calculating the fair value of the share offering at the cost of the service provided.</span></span></p> </div>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
118845 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
41500 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>f.</strong> <strong>Accounting Estimates</strong></span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of consolidated financial statements in conformity with U.S GAAP requires us to make certain estimates, judgements and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company's accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations.</span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates.</span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant accounting estimates and assumptions are used for, but not limited to:</span></span></p> <p style="margin-left:54pt;text-indent:-18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a) The Valuation of Deferred Tax Assets</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Judgement is required in determining whether deferred tax assets are recognized on the balance sheet. The recognition of deferred tax assets requires management to assess the likelihood that the Company will generate taxable income in future periods to utilize the deferred tax assets. Due to the Company's history of losses, deferred tax assets have not been recognized by the Company.</span></span></p> <div></div> <p style="margin-left:36pt;text-align:justify;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b) Value of Stock Options</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company provides compensation benefits to its employees, directors, officers, and consultants, through a stock option plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model. Expected volatility assumption used in the model is based on the historical volatility of the Company's share price. The Company uses historical data to estimate the period of option exercises for use in the valuation model. The risk-free interest rate for the expected term of the option is based on the yields of government bonds. Changes in these assumptions, especially the share price volatility and the expected life determination could have a material impact on the Company's profit and loss for the periods presented. All estimates used in the model are based on historical data which may not be representative of future results.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c) Fair value of shares issued in non cash transactions</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company at times grants common shares in lieu of cash to certain vendors for their services to the Company. The Company recognizes the associated cost in the same period and manner as if the Company paid cash for the services provided by calculating the fair value of the share offering at the cost of the service provided.</span></span></p> </div>
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>n.</strong> <strong>Concentration of credit risk</strong></span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company places its cash with high credit quality financial institutions.</span></span></p> </div>
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>n.</strong> <strong>Concentration of credit risk</strong></span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company places its cash with high credit quality financial institutions.</span></span></p> </div>
CY2024 enrt Drilling Expenses
DrillingExpenses
0 usd
CY2023 enrt Geologists Expenses
GeologistsExpenses
77379 usd
CY2024 enrt Sample Assays
SampleAssays
21175 usd
CY2023 enrt Sample Assays
SampleAssays
31441 usd
CY2024 enrt Travel And Other Expenses
TravelAndOtherExpenses
19943 usd
CY2023 enrt Travel And Other Expenses
TravelAndOtherExpenses
30675 usd
CY2024 us-gaap Exploration Expense
ExplorationExpense
55480 usd
CY2023 us-gaap Exploration Expense
ExplorationExpense
464665 usd
CY2024 enrt Geologists Expenses
GeologistsExpenses
14362 usd
CY2024 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
between 5-1 to 20-1 shares outstanding
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
between 5-1 to 20-1 shares outstanding
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
enrt Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
50000 shares
enrt Number Of Warrants Exercised
NumberOfWarrantsExercised
50000 shares
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024 enrt Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod
0 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.09
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q3 us-gaap Share Price
SharePrice
0.009
CY2024Q3 enrt Prepaid Expenses Current Exploration Costs
PrepaidExpensesCurrentExplorationCosts
22673 usd
CY2023Q3 enrt Prepaid Expenses Current Exploration Costs
PrepaidExpensesCurrentExplorationCosts
28400 usd
CY2024Q3 enrt Prepaid Expenses Fees And Dues
PrepaidExpensesFeesAndDues
9256 usd
CY2023Q3 enrt Prepaid Expenses Fees And Dues
PrepaidExpensesFeesAndDues
0 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024 enrt Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod
0 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y10M28D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023 enrt Class Of Warrant Or Right Forfeited In Period Weighted Average Exercise Price
ClassOfWarrantOrRightForfeitedInPeriodWeightedAverageExercisePrice
0.04
CY2023 enrt Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
50000 shares
CY2023 enrt Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice
0.04
CY2024Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
0 usd
CY2024Q3 enrt Prepaid Expenses Current Consultants
PrepaidExpensesCurrentConsultants
12000 usd
CY2023Q3 enrt Prepaid Expenses Current Consultants
PrepaidExpensesCurrentConsultants
8000 usd
CY2023Q3 enrt Prepaid Expenses Fees And Dues
PrepaidExpensesFeesAndDues
0 usd
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
33720 usd
CY2023Q3 enrt Prepaid Expenses Current Office Expenses
PrepaidExpensesCurrentOfficeExpenses
30 usd
CY2024Q3 enrt Prepaid Expenses Research And Development
PrepaidExpensesResearchAndDevelopment
0 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
89338 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
566819 usd
CY2024Q3 enrt Deferred Tax Assets Marketable Securities
DeferredTaxAssetsMarketableSecurities
79339 usd
CY2023Q3 enrt Deferred Tax Assets Marketable Securities
DeferredTaxAssetsMarketableSecurities
206303 usd
CY2023Q3 enrt Deferred Tax Assets Mineral Property
DeferredTaxAssetsMineralProperty
25465 usd
CY2024Q3 enrt Prepaid Expenses Research And Development
PrepaidExpensesResearchAndDevelopment
0 usd
CY2023Q3 enrt Prepaid Expenses Research And Development
PrepaidExpensesResearchAndDevelopment
5400 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
78794 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q3 enrt Deferred Tax Assets Marketable Securities
DeferredTaxAssetsMarketableSecurities
79339 usd
CY2023Q3 enrt Deferred Tax Assets Marketable Securities
DeferredTaxAssetsMarketableSecurities
206303 usd
CY2023Q3 enrt Deferred Tax Assets Mineral Property
DeferredTaxAssetsMineralProperty
25465 usd
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
10500 usd
CY2023Q3 us-gaap Noncurrent Assets
NoncurrentAssets
10500 usd

Files In Submission

Name View Source Status
0001062993-24-019582-index-headers.html Edgar Link pending
0001062993-24-019582-index.html Edgar Link pending
0001062993-24-019582.txt Edgar Link pending
0001062993-24-019582-xbrl.zip Edgar Link pending
enrt-20240831.xsd Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
form10kxz001.jpg Edgar Link pending
form10kxz002.jpg Edgar Link pending
form10kxz003.jpg Edgar Link pending
form10kxz004.jpg Edgar Link pending
enrt-20240831_cal.xml Edgar Link unprocessable
enrt-20240831_def.xml Edgar Link unprocessable
enrt-20240831_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
enrt-20240831_lab.xml Edgar Link unprocessable
form10kxz005.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
form10k_htm.xml Edgar Link completed